About Baxter
Baxter is a company based in Deerfield (United States) founded in 1931 was acquired by Warburg Pincus in October 2023. The company has 38,000 employees as of December 31, 2024. Baxter has completed 20 acquisitions, including AesRx, ApaTech and Caremark. Baxter offers products and services including Infusion Pumps, Nutritional Products, and Respiratory Therapies. Baxter operates in a competitive market with competitors including GE Healthcare, Medtronic, Boston Scientific, CONMED and Johnson & Johnson, among others.
- Headquarter Deerfield, United States
- Employees 38000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Baxter International Inc.
-
Annual Revenue
$10.64 B (USD)2.66as on Dec 31, 2024
-
Net Profit
-$649 M (USD)-187.17as on Dec 31, 2024
-
EBITDA
$1.68 B (USD)-10.76as on Dec 31, 2024
-
Latest Funding Round
$3.09 M (USD), Grant
May 19, 2022
-
Investors
Warburg Pincus
& 3 more
-
Employee Count
38000
as on Dec 31, 2024
-
Investments & Acquisitions
AesRx
& 19 more
-
Acquired by
Warburg Pincus
(Oct 02, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Baxter
Baxter is a publicly listed company on the NYSE with ticker symbol BAX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Baxter
Baxter offers a comprehensive portfolio of products and services, including Infusion Pumps, Nutritional Products, and Respiratory Therapies.
Devices for delivering medications and fluids to patients
Solutions for patients unable to self-feed
Products to simplify breathing treatments
People of Baxter
Unlock access to complete
Unlock access to complete
Software Development Team
288 people
Leadership Team
121 people
Sales and Marketing
70 people
Senior Team
38 people
Operations Team
30 people
Product Management Team
27 people
Human Resources and Administration
25 people
Finance and Accounting
20 people
Unlock access to complete
Funding Insights of Baxter
Investors in Baxter
Baxter has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Warburg Pincus, European Union and BMBF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Baxter
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Baxter
Baxter has strategically engaged in corporate development activities, having acquired 20 companies. Notable acquisitions include AesRx, ApaTech and Caremark.
Investment portfolio details for Baxter
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Body worn sensor to remotely monitor chronic diseases vitals, EvoNexus Alum.
|
Locked | Locked | 2014 | Locked | |
|
Management, surveillance and reporting software for antimicrobial stewardship and infection prevention
|
Locked | Locked | 2011 | Locked | |
|
Prophylactic treatments for sickle cell disease were developed.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Baxter
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Baxter
Detailed financials for Baxter
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Baxter Comparisons
Peer comparison for Baxter
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Baxter
Baxter operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Medtronic, Boston Scientific, CONMED and Johnson & Johnson, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Materials management solutions are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| Locked | Locked | Locked |
Wide range of medical devices
|
|
| Locked | Locked | Locked |
Surgical instruments are manufactured for multiple therapeutic areas.
|
|
| Locked | Locked | Locked |
Healthcare solutions are provided by Johnson & Johnson globally.
|
|
| Locked | Locked | Locked |
Complex healthcare challenges are addressed through technology solutions by Commure.
|
Detailed competitors of Baxter
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Baxter
Complete news archive for Baxter
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Baxter
Baxter was founded in 1931 and raised its 1st funding round 81 years after it was founded.
Baxter is headquartered in Deerfield, United States.
Jose E Almeida is the current CEO of Baxter.
As of Dec 31, 2024, the latest employee count at Baxter is 38,000.
Annual revenue of Baxter is $10.64B as on Dec 31, 2024.
Founded in 1931 and headquartered in Deerfield, United States, products for treating hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other medical conditions are developed, manufactured, and marketed by the company. Operations are divided into BioScience, Medication Delivery, and Renal segments, covering recombinant proteins, intravenous solutions, infusion systems, and renal therapies. In 2023, annual revenues of 15.05 billion were recorded alongside a net loss of 2.46 billion.
Baxter's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Baxter offers Infusion Pumps, Nutritional Products, and Respiratory Therapies.
Yes, Baxter is publicly traded on NYSE under the ticker symbol BAX.
Baxter has 4 investors. Key investors include Warburg Pincus, European Union, BMBF, and Advent International.
The ticker symbol of Baxter is BAX on NYSE.